Standard

CAS No.

Usage

Paclitaxel

USP32

33069-62-4

Oncology

Docetaxel(Anhydrous)

Enterprise

114977-28-5

Oncology

Docetaxel (Trihydrate)

Enterprise

148408-66-6

Oncology

Irinotecan HCl

Enterprise

136572-09-3

Oncology

Mitomycin C

USP32

50-07-7

Oncology

Etoposide

USP30

33419-42-0

Oncology

Carboplatin

USP32

41575-94-4

Oncology

Cisplatin

USP32

15663-27-1

Oncology

Oxaliplatin

EP6

61825-94-3

Oncology

Fludarabine Phosphate

USP30

75607-67-9

Oncology

Imatinib Mesylate

Enterprise

220127-57-1

Oncology

Erlotinib HCl

Enterprise

183319-69-9

Oncology

Palonosetron HCl

Enterprise

135729-62-3

Oncology

Capecitabine

USP32

154361-50-9

Oncology

Temozolomide

Enterprise

85622-93-1

Oncology

Triethylenethiophosphoramide

USP30

52-24-4

Oncology

Decitabine

Enterprise

2353-33-5

Oncology

Bendamustine HCl

Enterprise

3543-75-7

Oncology

Ifosfamide

USP29

3778-73-2

Oncology

Bortezomib

Enterprise

179324-69-7

Oncology

Lapatinib

Enterprise

231277-92-2

Oncology

Gefitinib

Enterprise

184475-35-2

Oncology

Sunitinib

Enterprise

557795-19-4

Oncology

Sorafenib

Enterprise

284461-73-0

Oncology

Nelarabine

Enterprise

121032-29-2

Oncology

Anastrozole

Enterprise

120511-73-1

Oncology

Pemetrexed Disodium

Enterprise

150399-23-8

Oncology

Bicalutamide

Enterprise

90357-06-5

Oncology

Vinorelbine Tartrate

USP31

125317-39-7

Oncology

Gemcitabine HCl

USP32

122111-03-9

Oncology

Tamibarotene

Enterprise

94497-51-5

Oncology

Tropisetron HCl

EP5

105826-92-4

Oncology